TOKYO -- Kobayashi Pharmaceutical will spend 30 billion yen ($254 million) over the three years through fiscal 2019 to buy businesses in China and elsewhere to bolster drug sales outside its home market of Japan.
This marks the company's first time revealing investment plans.
